CIK 0000899460
- Large accelerated filer
MANNKIND CORP
Sign in to watch- Ticker
- MNKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133607736
- Phone
- +1 818-661-5000
- Business address
- 1 CASPER STREET, DANBURY, CT, 06810
- 4 Grant or award Chief Executive Officer acquired 60,403 shares (grant or award)
- 4 Grant or award Director acquired 32,608 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Chief Financial Officer bought 1,860 shares at $1.07 ($1,990)
- 4 Open-market buy Corp VP, Chief People Officer bought 5,000 shares at $1.07 ($5,350)
- 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $1.07 ($5,350)
- 4 Open-market buy Chief Medical Officer bought 5,000 shares at $1.07 ($5,350)
- 4 Open-market buy Chief Marketing Officer bought 5,000 shares at $1.07 ($5,350)
- 4 Open-market buy Chief Compliance Officer bought 5,000 shares at $1.07 ($5,350)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $1.07 ($5,350)
- 4 Grant or award Chief Medical Officer acquired 2,824 shares (grant or award)
- 4 Grant or award Corp VP, Chief People Officer acquired 14,124 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 14,124 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 25,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Corp VP, Chief People Officer bought 5,000 shares at $1.31 ($6,550)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $1.31 ($6,550)
Page 19 of 50 · 999 filings